JP2022016725A - Pain relief method, liquid, and medical device - Google Patents

Pain relief method, liquid, and medical device Download PDF

Info

Publication number
JP2022016725A
JP2022016725A JP2018209239A JP2018209239A JP2022016725A JP 2022016725 A JP2022016725 A JP 2022016725A JP 2018209239 A JP2018209239 A JP 2018209239A JP 2018209239 A JP2018209239 A JP 2018209239A JP 2022016725 A JP2022016725 A JP 2022016725A
Authority
JP
Japan
Prior art keywords
pain
lumen
medical device
liquid
distilled water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018209239A
Other languages
Japanese (ja)
Inventor
涼 経田
Ryo Kyoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP2018209239A priority Critical patent/JP2022016725A/en
Priority to PCT/JP2019/030565 priority patent/WO2020095496A1/en
Publication of JP2022016725A publication Critical patent/JP2022016725A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • A61P23/02Local anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

To provide a pain relief method capable of relieving pain during childbirth without relying on epidural anesthesia.SOLUTION: A pain relief method according to the invention uses a medical device 100 having a lumen 14 previously filled with sterilized distilled water 15 and an injection needle 27 to form puncture points P1 to P4 in the skin of the waist of a pregnant woman during delivery, and inject the sterilized distilled water into the puncture points from the lumen of the medical device through the injection needle 27 thereof to stimulate a nerve with a faster conduction velocity than a nerve stimulated by uterine contraction.SELECTED DRAWING: Figure 3

Description

本発明は、疼痛軽減方法、液体及び医療器具に関する。 The present invention relates to pain relief methods, liquids and medical devices.

妊婦は、自然分娩による出産の際に多大なる痛みを経験することから、その痛みを緩和する方法について鋭意研究がなされている。一般的な自然分娩においては、分娩時に陣痛が始まるが、この陣痛が強い腰痛として感知されることが少なくない。このような腰痛は、いわゆる一般的な腰痛と異なり、子宮が収縮することによって起きるものである。この腰痛によって妊婦は起立困難になる場合もあり、妊婦の体力消耗の大きな原因となっている。 Pregnant women experience a great deal of pain during childbirth due to natural childbirth, and much research has been done on how to relieve that pain. In general spontaneous delivery, labor begins at the time of delivery, and this labor is often perceived as strong low back pain. Such low back pain is caused by contraction of the uterus, unlike so-called general low back pain. This back pain may make it difficult for pregnant women to stand up, which is a major cause of physical exhaustion in pregnant women.

このような分娩時の痛みを軽減する方法として、和痛方法ではアロマテラピーやマッサージがあるものの、その効果は曖昧である。また、無痛分娩には陰部神経ブロックや硬膜外麻酔による局所麻酔又は静脈点滴による全身麻酔があり、一般的には硬膜外麻酔が行われ、硬膜外麻酔が実施できない場合に静脈点滴が実施される。硬膜外麻酔に関する技術として、特許文献1には硬膜外麻酔を行う際に重炭酸塩や硝酸塩、又はリン酸塩等を含む組成物を投与する技術が開示されている。 Aromatherapy and massage are available as methods for reducing such pain during labor, but their effects are ambiguous. In addition, painless delivery includes local anesthesia by pudendal nerve block or epidural anesthesia or general anesthesia by intravenous infusion. Generally, epidural anesthesia is performed, and when epidural anesthesia cannot be performed, intravenous infusion is performed. Will be implemented. As a technique relating to epidural anesthesia, Patent Document 1 discloses a technique for administering a composition containing a bicarbonate, a nitrate, a phosphate or the like when performing epidural anesthesia.

特表2017-508004号公報Special Table 2017-508004

特許文献1のような硬膜外麻酔を用いる方法のメリットは、除痛効果が高く、母体の意識も明瞭で、麻酔薬が胎児に影響することもなく、そのまま帝王切開を行える等が挙げられる。ただし、硬膜外麻酔のデメリットには麻酔中毒等の重大な合併症が起こる可能性がある。そのため、硬膜外麻酔を実施する医療機関では経験豊富な麻酔科医等の医師の存在や緊急時に対応できる施設体制等が必要となる。しかし、わが国において麻酔科医の数は不足しており、全ての妊婦に対して経験豊富な麻酔科医が必ずしも担当できるとは限らない。 The merits of the method using epidural anesthesia as in Patent Document 1 are that the pain-relieving effect is high, the mother's consciousness is clear, the anesthetic does not affect the fetus, and the caesarean section can be performed as it is. .. However, the disadvantage of epidural anesthesia may be serious complications such as anesthesia poisoning. Therefore, medical institutions that perform epidural anesthesia need the presence of experienced anesthesiologists and other doctors and a facility system that can respond to emergencies. However, the number of anesthesiologists is insufficient in Japan, and it is not always possible for an experienced anesthesiologist to be in charge of all pregnant women.

そこで本発明は、硬膜外麻酔によらずに出産時の腰部の痛みを軽減できる疼痛軽減方法を提供することを目的とする。 Therefore, an object of the present invention is to provide a pain reducing method capable of reducing lower back pain during childbirth without using epidural anesthesia.

上記目的を達成する本発明に係る疼痛軽減方法は、内腔と穿刺部とを備え、前記内腔に液体が予め充填された医療器具の前記穿刺部を用いて分娩中の妊婦の腰部における皮内に穿刺箇所を形成する。そして、前記内腔から前記穿刺箇所に前記液体を注入することによって子宮収縮により刺激される神経よりも伝導速度の速い神経に刺激を付与する。また、本発明は上記疼痛軽減方法に用いられる液体である。また、本発明は上記内腔に液体が予め充填された医療器具である。 The pain-relieving method according to the present invention, which achieves the above object, has a lumen and a puncture portion, and the skin in the lumbar region of a pregnant woman during delivery using the puncture portion of a medical device in which the lumen is prefilled with liquid. A puncture site is formed inside. Then, by injecting the liquid from the lumen into the puncture site, the nerve having a faster conduction rate than the nerve stimulated by the uterine contraction is stimulated. Further, the present invention is a liquid used in the above-mentioned pain relief method. Further, the present invention is a medical device in which the lumen is pre-filled with a liquid.

本発明に係る疼痛軽減方法、疼痛軽減方法に用いられる液体及び医療器具によれば、医療器具の内腔から妊婦の腰部における皮内に液体を注入することによって、硬膜外麻酔によらずに分娩時における妊婦の腰部の痛みを軽減することができる。 According to the pain-relieving method, the liquid used in the pain-relieving method, and the medical device according to the present invention, by injecting the liquid into the skin in the lumbar region of a pregnant woman from the lumen of the medical device, without epidural anesthesia. It is possible to reduce the pain in the lower back of a pregnant woman at the time of delivery.

本発明の一実施形態に係る疼痛軽減方法に用いられる医療器具を分解して示す正面図である。It is a front view which shows disassembled the medical device used for the pain relief method which concerns on one Embodiment of this invention. 図1に示す医療器具における穿刺部の先端を示す拡大図である。It is an enlarged view which shows the tip of the puncture part in the medical device shown in FIG. 図1に示す医療器具の部分断面図である。It is a partial cross-sectional view of the medical device shown in FIG. 図1に示す医療器具によって穿刺される人体の穿刺箇所を示す腰部付近の図である。It is a figure in the vicinity of the lumbar region which shows the puncture point of the human body punctured by the medical device shown in FIG. 1. 本発明の一実施形態に係る疼痛軽減方法を示すフローチャートである。It is a flowchart which shows the pain relief method which concerns on one Embodiment of this invention. 図1におけるシリンジ本体の変形例を示す部分断面図である。It is a partial cross-sectional view which shows the modification of the syringe body in FIG.

以下、添付した図面を参照しながら、本発明の実施形態を説明する。図1は、本発明の一実施形態に係る疼痛軽減方法に用いられる医療器具100を分解して示す正面図である。図2は、図1に示す医療器具100の穿刺部の先端を示す拡大図である。図3は図1に示す医療器具100の部分断面図である。本実施形態に係る疼痛軽減方法は、自然分娩等によって出産を行う妊婦の腰痛等を軽減するために用いられる。まず、疼痛軽減方法の説明にあたり、本実施形態に係る疼痛軽減方法に用いられる医療器具100について説明する。 Hereinafter, embodiments of the present invention will be described with reference to the attached drawings. FIG. 1 is a front view showing the medical device 100 used in the pain reduction method according to the embodiment of the present invention in an exploded manner. FIG. 2 is an enlarged view showing the tip of the puncture portion of the medical device 100 shown in FIG. FIG. 3 is a partial cross-sectional view of the medical device 100 shown in FIG. The pain reducing method according to the present embodiment is used to reduce low back pain in a pregnant woman who gives birth by natural childbirth or the like. First, in explaining the pain reduction method, the medical device 100 used in the pain reduction method according to the present embodiment will be described.

(医療器具)
医療器具100は、図1に示すようにシリンジ本体10と、注射針組立体20と、を有する。
(Medical equipment)
The medical device 100 has a syringe body 10 and an injection needle assembly 20 as shown in FIG.

シリンジ本体10は、図1に示すように押し子11と、外筒12と、ロック機構16と、筒先17と、キャップ18と、を備える。押し子11は、内腔14に充填された液体を後述する注射針27に向けて押出すように構成している。内腔14は外筒12の内部に設けるように構成している。押し子11は、外筒12の内腔14に挿入可能に構成している。押し子11は、先端にゴム等によって形成されたガスケット13が取り付けられ、ガスケット13とともに外筒12の内腔14に挿入可能に構成している。 As shown in FIG. 1, the syringe body 10 includes a pusher 11, an outer cylinder 12, a lock mechanism 16, a cylinder tip 17, and a cap 18. The pusher 11 is configured to push out the liquid filled in the lumen 14 toward the injection needle 27 described later. The lumen 14 is configured to be provided inside the outer cylinder 12. The pusher 11 is configured to be insertable into the lumen 14 of the outer cylinder 12. A gasket 13 formed of rubber or the like is attached to the tip of the pusher 11, and the pusher 11 is configured to be insertable into the lumen 14 of the outer cylinder 12 together with the gasket 13.

押し子11の基端は、図1に示すように外筒12から露出するように構成している。外筒12の内腔14には、滅菌された蒸留水15が使用前に予め液密に封入されるように構成している。滅菌された蒸留水15は、本明細書において妊婦の腰部における皮内に注入(投与)される液体に相当する。本明細書における「液体」とは、硬膜外麻酔のように麻酔科医でなくても出産時に妊婦への投与が可能なものを意味する。 The base end of the pusher 11 is configured to be exposed from the outer cylinder 12 as shown in FIG. The lumen 14 of the outer cylinder 12 is configured so that the sterilized distilled water 15 is preliminarily liquid-tightly sealed before use. The sterilized distilled water 15 corresponds to the liquid injected (administered) into the skin in the waist of a pregnant woman in the present specification. As used herein, the term "liquid" means an epidural anesthesia that can be administered to a pregnant woman at the time of delivery without being an anesthesiologist.

本実施形態において滅菌した蒸留水15は、蒸留水に滅菌処理を施していれば特に限定されないが、例示すれば逆浸透圧法と蒸留法により製造したものや、蒸留水を高圧蒸気滅菌したもの等を挙げることができる。筒先17は、外筒12から延在しており、図3に示すように内部に基端側よりも径を小さく構成した内腔14を設けている。 The distilled water 15 sterilized in the present embodiment is not particularly limited as long as the distilled water is sterilized. Can be mentioned. The cylinder tip 17 extends from the outer cylinder 12, and as shown in FIG. 3, a lumen 14 having a diameter smaller than that of the proximal end side is provided inside.

ロック機構16は、図3に示すように本実施形態においてキャップ18と螺合可能な雌ねじによって構成している。キャップ18には雄ねじが設けられ、キャップ18の雄ねじとロック機構16に係る雌ねじとを螺合させることによって内腔14に収容された蒸留水15が封止されるように構成している。
注射針組立体20は、図1に示すように係合筒22と、弾性体23と、針ハブ24と、安定部26と、注射針27(穿刺部に相当)と、を備える。係合筒22は、図3に示すようにロック機構16に係る雌ねじと螺合可能な雄ねじを外周面に設けている。針ハブ24は、注射針組立体20の先端において注射針27を保持するように構成している。
弾性体23は、図3に示すようにロック機構16と係合筒22とが係合することによって筒先17及び針ハブ24の間に設けられた隙間を埋めるように構成している。注射針27は、針先から針基端に連通する針穴が設けられ、針先に刃面を備えた針管を設けている。注射針27は、針ハブ24の調整部25から突出するように構成している。安定部26は、針ハブ24の針先において中空の筒状に形成し、調整部25を径方向外方から包囲するように構成している。
As shown in FIG. 3, the lock mechanism 16 is configured by a female screw that can be screwed with the cap 18 in the present embodiment. A male screw is provided on the cap 18, and the male screw of the cap 18 and the female screw related to the lock mechanism 16 are screwed so that the distilled water 15 contained in the lumen 14 is sealed.
As shown in FIG. 1, the injection needle assembly 20 includes an engaging cylinder 22, an elastic body 23, a needle hub 24, a stabilizing portion 26, and an injection needle 27 (corresponding to a puncture portion). As shown in FIG. 3, the engaging cylinder 22 is provided with a male screw that can be screwed with the female screw related to the lock mechanism 16 on the outer peripheral surface. The needle hub 24 is configured to hold the injection needle 27 at the tip of the injection needle assembly 20.
As shown in FIG. 3, the elastic body 23 is configured to fill the gap provided between the cylinder tip 17 and the needle hub 24 by engaging the lock mechanism 16 and the engaging cylinder 22. The injection needle 27 is provided with a needle hole that communicates from the needle tip to the needle base end, and is provided with a needle tube having a blade surface at the needle tip. The injection needle 27 is configured to protrude from the adjusting portion 25 of the needle hub 24. The stabilizing portion 26 is formed in a hollow tubular shape at the needle tip of the needle hub 24, and is configured to surround the adjusting portion 25 from the outside in the radial direction.

図2に示すように注射針27の針先から調整部25の針先側端面までの長さL1は、最長で2mm程度であり、針胴長L2は最短で1mm程度で、26~25ゲージ(直径0.45~0.15mmに相当)となるように構成している。 As shown in FIG. 2, the length L1 from the needle tip of the injection needle 27 to the needle tip side end surface of the adjusting portion 25 is about 2 mm at the longest, and the needle barrel length L2 is about 1 mm at the shortest, and is 26 to 25 gauge. It is configured to be (corresponding to a diameter of 0.45 to 0.15 mm).

注射針組立体20は、図1に示すように使用直前まで一体に構成された包装容器21bと包装蓋21aによって包囲され、包装蓋21aを包装容器21bから剥離して分離することによって取り出し可能に構成している。 As shown in FIG. 1, the injection needle assembly 20 is surrounded by a packaging container 21b and a packaging lid 21a integrally configured until just before use, and can be taken out by peeling the packaging lid 21a from the packaging container 21b and separating it. It is composed.

医療器具100を構成する部材の材料は特に限定されないが、例示すれば以下のようになる。外筒12、ロック機構16、筒先17、係合筒22、針ハブ24、調整部25及び安定部26はポリプレロピレン、ポリエチレン、シクロオレフィンポリマー等によって構成できる。 The material of the member constituting the medical device 100 is not particularly limited, but is as follows, for example. The outer cylinder 12, the locking mechanism 16, the cylinder tip 17, the engaging cylinder 22, the needle hub 24, the adjusting portion 25, and the stabilizing portion 26 can be made of polyprelopylene, polyethylene, cycloolefin polymer, or the like.

ガスケット13及び弾性体23については、天然ゴム、シリコーンゴムのような各種ゴム材料や、ポリウレタン系、スチレン系等の各種熱可塑性エラストマー、或いはそれらの混合物等によって構成できる。注射針27については、ステンレス鋼、アルミニウム、アルミニウム合金、チタン、チタン合金その他の金属によって構成することができる。 The gasket 13 and the elastic body 23 can be made of various rubber materials such as natural rubber and silicone rubber, various thermoplastic elastomers such as polyurethane and styrene, or a mixture thereof. The injection needle 27 can be made of stainless steel, aluminum, aluminum alloy, titanium, titanium alloy or other metal.

(疼痛軽減方法)
次に本実施形態に係る疼痛軽減方法について説明する。図4は図1に示す医療器具100によって穿刺される人体の穿刺箇所を示す腰部付近の(背面)図である。図5は、本発明の一実施形態に係る疼痛軽減方法について示すフローチャートである。
(Pain reduction method)
Next, the pain reduction method according to the present embodiment will be described. FIG. 4 is a (back) view of the vicinity of the lumbar region showing the puncture site of the human body punctured by the medical device 100 shown in FIG. FIG. 5 is a flowchart showing a pain reduction method according to an embodiment of the present invention.

まず、内腔14に滅菌した0.1mlの蒸留水15が予め充填された医療器具100を用意する。次に、妊婦は医師や助産師の指示を受けて公知の分娩台(図示省略)に仰臥等の姿勢で横になる(ST1)。そして、一時的に背中の中でも穿刺箇所P1~P4である腰部付近が医師に対して対向するように姿勢を変える。 First, a medical device 100 in which the lumen 14 is pre-filled with 0.1 ml of sterilized distilled water 15 is prepared. Next, the pregnant woman lies on a known delivery table (not shown) in a supine position (ST1) under the direction of a doctor or midwife. Then, the posture is temporarily changed so that the vicinity of the lumbar region, which is the puncture points P1 to P4, faces the doctor even in the back.

次に、医師は包装蓋21aを包装容器21bから剥離して分離し、包装容器21bから注射針組立体20を取り出す。そして、シリンジ本体10のキャップ18を筒先17から取り外し、筒先17に注射針組立体20の係合筒22の雄ねじとロック機構16の雌ねじとを螺合する。これにより、注射針組立体20がシリンジ本体10に取り付けられる。そして、筒先17と針ハブ24との間の隙間が弾性体23の弾性変形によって隙間なく埋められ、液密状態となる。 Next, the doctor peels off the packaging lid 21a from the packaging container 21b to separate it, and takes out the injection needle assembly 20 from the packaging container 21b. Then, the cap 18 of the syringe body 10 is removed from the cylinder tip 17, and the male screw of the engaging cylinder 22 of the injection needle assembly 20 and the female screw of the lock mechanism 16 are screwed into the cylinder tip 17. As a result, the injection needle assembly 20 is attached to the syringe body 10. Then, the gap between the cylinder tip 17 and the needle hub 24 is completely filled by the elastic deformation of the elastic body 23, and the liquid-tight state is established.

次に、医師は、図4に示すように注射針組立体20の注射針27の針先を穿刺部位である腰部付近の穿刺箇所P1~P4に向ける。次に、医師は、妊婦の腰部付近と対向した状態において医療器具100を用いて滅菌した蒸留水15を略0.1ml、妊婦の脊柱上を除く左右2箇所、計4箇所(図4の穿刺箇所P1~P4参照)に皮内投与(注入)する(ST2)。 Next, as shown in FIG. 4, the doctor points the needle tip of the injection needle 27 of the injection needle assembly 20 toward the puncture points P1 to P4 near the waist, which is the puncture site. Next, the doctor put about 0.1 ml of distilled water 15 sterilized using the medical device 100 in a state facing the vicinity of the waist of the pregnant woman, and two places on the left and right except on the spinal column of the pregnant woman, for a total of four places (puncture in FIG. 4). Intradermal administration (injection) to sites P1 to P4) (ST2).

次に、医師等は、医療器具100を注射針27が皮膚30に対して垂直となるように押し付ける。これにより、注射針27の針先が皮膚30に穿刺される。それとともに安定部26が皮膚30の皮膚表皮33を押し当て、調整部25が皮膚表皮33に接触する結果、調整部25と安定部26によって皮膚表皮33の表面が引っ張られ、針ハブ24によって医療器具100が穿刺箇所に対して固定(安定化)される。 Next, the doctor or the like presses the medical device 100 so that the injection needle 27 is perpendicular to the skin 30. As a result, the needle tip of the injection needle 27 is punctured into the skin 30. At the same time, the stabilizing portion 26 presses the skin epidermis 33 of the skin 30 and the adjusting portion 25 contacts the skin epidermis 33. As a result, the surface of the skin epidermis 33 is pulled by the adjusting portion 25 and the stabilizing portion 26, and the needle hub 24 provides medical treatment. The instrument 100 is fixed (stabilized) to the puncture site.

注射針27は、針先の鋭利な刃面によって皮膚表皮33を貫通し、刃面の針穴の開口が丁度皮膚上層部の皮内32のうち、皮膚表皮33の表面から1~4mmの比較的浅い皮内標的部位に達するが、皮下組織31には達しない位置となる。この状態で押し子11を押し切って滅菌された蒸留水15を注入する。これにより、皮膚表皮33の表面より1~4mmの深さである皮内32へ滅菌された蒸留水15が到達する。 The injection needle 27 penetrates the skin epidermis 33 by the sharp blade surface of the needle tip, and the opening of the needle hole on the blade surface is just 1 to 4 mm from the surface of the skin epidermis 33 among the intradermal 32 in the upper layer of the skin. It reaches the shallow intradermal target site, but does not reach the subcutaneous tissue 31. In this state, the pusher 11 is pushed all the way out and sterilized distilled water 15 is injected. As a result, the sterilized distilled water 15 reaches the inside of the skin 32, which is 1 to 4 mm deep from the surface of the skin epidermis 33.

蒸留水15を投与した後は、妊婦が分娩台の上において仰臥位となり、左右の大腿及び下腿を離間するように開いて分娩台の足置きに載せる。そして、医師又は助産師の指示に従って、上体を起こすなど体位を変化させたり、いきんだり、深呼吸したりしながら、子宮口より胎児を分娩する(ST3)。 After the administration of the distilled water 15, the pregnant woman is in the supine position on the delivery table, and the left and right thighs and lower legs are opened so as to be separated from each other and placed on the footrest of the delivery table. Then, according to the instructions of the doctor or midwife, the fetus is delivered from the uterine ostium while changing the position such as raising the upper body, breathing, and taking a deep breath (ST3).

本方法において、腰部の穿刺箇所P1~P4の皮内32に蒸留水15を投与した後は、投与部位に一時的に痛みを感じるものの、その痛みは略30秒程度~数分程度で消失し、除痛効果を発現する。本実施形態に係る疼痛軽減方法は、硬膜外麻酔による方法と比べて除痛効果が早く発現することが期待できる。 In this method, after the distilled water 15 is administered to the intracutaneous 32 of the puncture points P1 to P4 of the lumbar region, a temporary pain is felt at the administration site, but the pain disappears in about 30 seconds to several minutes. , Exhibits a pain-relieving effect. The pain-relieving method according to the present embodiment is expected to have a faster pain-relieving effect than the method using epidural anesthesia.

また、本実施形態に係る疼痛軽減方法は、無処置やマッサージ等と比較して有意な除痛効果が期待できる。除痛の持続時間は最大2時間程度であり、蒸留水15の繰り返しの投与も可能である。 In addition, the pain-relieving method according to the present embodiment can be expected to have a significant pain-relieving effect as compared with no treatment or massage. The duration of pain relief is up to about 2 hours, and repeated administration of distilled water 15 is also possible.

本方法に基づく疼痛軽減方法は、いわゆるゲートコントロール理論に基づくと考えられる。すなわち、出産の際の陣痛における子宮収縮は、内臓痛覚であり、C神経線維を介する。C神経線維は、比較的細い無髄神経であり、伝導速度は遅い。これに対して、より太く伝導速度の速い神経線維(有髄神経)であるAβ神経線維(触覚・圧覚)やAδ神経線維(体性痛覚)を刺激することによって内臓痛覚を抑制する。これにより、内臓痛覚である子宮収縮による痛みが緩和される。 The pain reduction method based on this method is considered to be based on the so-called gate control theory. That is, uterine contractions in labor during childbirth are visceral pain sensations and are mediated by C nerve fibers. C nerve fibers are relatively thin unmyelinated nerves and have a slow conduction rate. On the other hand, the visceral pain sensation is suppressed by stimulating Aβ nerve fibers (tactile / pressure sensation) and Aδ nerve fibers (somatic pain sensation), which are thicker and faster conduction nerve fibers (myelinated nerves). This alleviates the pain caused by uterine contractions, which is a visceral pain sensation.

疼痛軽減(除痛)効果を得るためには皮膚に存在する神経を刺激する必要がある。このような神経は、皮下組織よりも皮膚(主に真皮層)に多く分布している。また、このような刺激は、薬剤の投与量(物理的な皮膚の圧迫)、浸透圧(痛み)、温度(冷たい、熱い)等によってもたらされる。 In order to obtain a pain-relieving (pain-relieving) effect, it is necessary to stimulate nerves existing in the skin. Such nerves are more distributed in the skin (mainly the dermis layer) than in the subcutaneous tissue. In addition, such irritation is brought about by the dose of the drug (physical skin compression), osmotic pressure (pain), temperature (cold, hot) and the like.

本方法によれば、妊婦はいきむことも可能である。本発明に係る疼痛軽減方法によれば、妊婦の意識に影響を与えず、行動を制限することもない。そのため、蒸留水15の注入後の分娩の進行に影響を与えないようにすることができる。また、本方法は、滅菌した蒸留水15を上述した箇所に皮内要与する程度であり、人手が必要であるのは投与時程度である。さらに、硬膜外麻酔のように専門知識を備えた医師でなくても処置が可能である。 According to this method, pregnant women can also live. According to the pain reducing method according to the present invention, the consciousness of the pregnant woman is not affected and the behavior is not restricted. Therefore, it is possible to prevent the progress of delivery after the injection of the distilled water 15 from being affected. Further, in this method, sterilized distilled water 15 is applied intradermally to the above-mentioned location, and manual labor is required only at the time of administration. Furthermore, treatment is possible even if the doctor does not have specialized knowledge, such as epidural anesthesia.

また、本方法は、母子に対して安全であり、少なくとも子供への副作用はない。さらに、本方法は、硬膜外麻酔のような麻酔を必要とせず、処置に必要な費用を安くすることができる。また、本実施形態に係る疼痛軽減方法は、ラマーズ法やマッサージ、アロマテラピー等の他の疼痛軽減方法との併用も可能である。 In addition, this method is safe for mothers and children, and at least has no side effects on children. Furthermore, this method does not require anesthesia such as epidural anesthesia, and the cost required for the procedure can be reduced. In addition, the pain-relieving method according to the present embodiment can be used in combination with other pain-relieving methods such as Lamaze method, massage, and aromatherapy.

以上、説明したように本実施形態に係る疼痛軽減方法は、内腔14と注射針27とを備え、内腔14に蒸留水15が予め充填された医療器具100の注射針27を用いて分娩中の妊婦の腰部に穿刺箇所P1~P4を形成する。そして、医療器具100の内腔14から穿刺箇所P1~P4の皮内に滅菌された蒸留水15を注入(投与)する。これにより、子宮収縮により刺激される神経よりも伝導速度の速い神経に刺激が付与される。 As described above, the pain relief method according to the present embodiment is provided with a cavity 14 and an injection needle 27, and delivery is performed using an injection needle 27 of a medical device 100 in which the lumen 14 is prefilled with distilled water 15. Puncture points P1 to P4 are formed on the waist of the pregnant woman inside. Then, sterilized distilled water 15 is injected (administered) from the lumen 14 of the medical device 100 into the skins of the puncture points P1 to P4. This stimulates nerves that have a faster conduction rate than nerves that are stimulated by uterine contractions.

本方法以外に出産時の妊婦の子宮収縮による痛みを軽減する方法には硬膜外麻酔がある。硬膜外麻酔による疼痛軽減効果は高く、母体の意識も明瞭で、麻酔が胎児に影響することはなく、そのまま帝王切開などもできると言われている。ただし、硬膜外麻酔は、いきみにくくなり、場合によっては発熱や低血圧となり、麻酔薬中毒等の重大な合併症を引き起こし、最悪の場合には死亡に至る可能性もある。 Epidural anesthesia is another method for reducing pain caused by uterine contractions in pregnant women during childbirth. It is said that epidural anesthesia has a high pain-relieving effect, the mother's consciousness is clear, the anesthesia does not affect the fetus, and a caesarean section can be performed as it is. However, epidural anesthesia becomes difficult to breathe, and in some cases, fever and hypotension occur, causing serious complications such as anesthetic poisoning, and in the worst case, death may occur.

そのため、硬膜外麻酔を実施するには麻酔薬の厳格な管理が要求されたり、専門知識を有する麻酔科医が必要とされ、さらに緊急時に対応可能な施設体制も必要とされる。日本では上述のように麻酔科医が十分いるとは言い難く、硬膜外麻酔に伴う夫婦の費用負担も軽いとは言い難い。 Therefore, in order to carry out epidural anesthesia, strict control of anesthetics is required, an anesthesiologist with specialized knowledge is required, and a facility system capable of responding to emergencies is also required. As mentioned above, it is hard to say that there are enough anesthesiologists in Japan, and it is hard to say that the cost burden for couples associated with epidural anesthesia is light.

これに対して、本実施形態に係る疼痛軽減方法では、妊婦の腰部に穿刺箇所P1~
4を形成して滅菌した蒸留水15を投与する程度であり、硬膜外麻酔に比べて簡便に手技を実施することができる。また、本方法による除痛効果は、投与後略30秒程度で発現し、最大で2時間程度持続し、繰り返しの蒸留水投与も可能である。
On the other hand, in the pain reduction method according to the present embodiment, the puncture site P1 to the waist of the pregnant woman
The procedure can be carried out more easily than epidural anesthesia, because the distilled water 15 formed by forming 4 and sterilized is administered. In addition, the pain-relieving effect of this method appears in about 30 seconds after administration, lasts for up to about 2 hours, and repeated administration of distilled water is possible.

さらに麻酔科医も不要で、ラマーズ法やマッサージ、及びアロマテラピー等の他の疼痛軽減方法との併用も可能である。また、本方法によれば、投与後に妊婦の意識にも影響を与えず、行動を制限することもなく、自然分娩が可能となり、その後の分娩の進展にも影響を与えないようにすることができる。 Furthermore, no anesthesiologist is required, and it can be used in combination with other pain-relieving methods such as Lamaze method, massage, and aromatherapy. In addition, according to this method, it is possible to deliver spontaneously without affecting the consciousness of the pregnant woman after administration, without restricting the behavior, and not to affect the progress of the subsequent delivery. can.

また、本方法では妊婦の腰部の皮内32に穿刺箇所P1~P4を形成することによって出産時の子宮収縮による痛みを軽減することができる。 In addition, in this method, pain due to uterine contraction during childbirth can be reduced by forming puncture points P1 to P4 in the intracutaneous 32 of the waist of a pregnant woman.

また、医療器具100の内腔14には滅菌された蒸留水15が使用前に予め充填するように構成している。そのため、手技の際に内腔14に蒸留水15を充填する作業と充填作業にかかる時間が不要になる。そのため、医師等の作業者の作業性を向上させるとともに、出産時に生じる妊婦の痛みを速やかに軽減することができる。 Further, the lumen 14 of the medical device 100 is configured to be pre-filled with sterilized distilled water 15 before use. Therefore, the time required for the work of filling the lumen 14 with the distilled water 15 and the filling work during the procedure becomes unnecessary. Therefore, it is possible to improve the workability of workers such as doctors and promptly reduce the pain of pregnant women caused during childbirth.

また、本実施形態に係る疼痛軽減方法によれば、妊婦の腰部の穿刺箇所P1~P4には滅菌された蒸留水15を注入している。滅菌蒸留水の取り扱いには硬膜外麻酔のような麻酔科医が不要と考えられるため、硬膜外麻酔に比べて専門知識や経験豊富な麻酔科医のいない医療機関であっても本実施形態に係る疼痛軽減方法を実施することができる。また、滅菌された蒸留水15は硬膜外麻酔に用いられる麻酔よりも安価であるため、出産時の子宮収縮に伴う疼痛軽減を望む妊婦への経済的な負担を軽減することにも寄与できる。 Further, according to the pain reducing method according to the present embodiment, sterilized distilled water 15 is injected into the puncture points P1 to P4 on the waist of the pregnant woman. Since it is considered that an anesthesiologist such as epidural anesthesia is not required to handle sterilized distilled water, this implementation is carried out even at medical institutions that do not have specialized knowledge or experienced anesthesiologists compared to epidural anesthesia. A morphologically pain-relieving method can be implemented. In addition, since the sterilized distilled water 15 is cheaper than the anesthesia used for epidural anesthesia, it can also contribute to reducing the financial burden on pregnant women who desire to reduce the pain associated with uterine contractions during childbirth. ..

また、本方法によれば、上記医療器具に滅菌した蒸留水15を用いることによって出産時の子宮収縮に伴う妊婦の疼痛軽減を図ることができる。 Further, according to this method, by using sterilized distilled water 15 for the medical device, it is possible to reduce pain in a pregnant woman due to uterine contraction during childbirth.

また、本実施形態によれば、内腔14に予め滅菌された蒸留水15を充填した医療器具100を用いることによって、出産時に妊婦に生じる腰部の痛みを軽減することができる。 Further, according to the present embodiment, by using the medical device 100 in which the lumen 14 is filled with distilled water 15 sterilized in advance, it is possible to reduce the pain in the lower back that occurs in a pregnant woman during childbirth.

なお、本発明は上述した実施形態のみに限定されず、特許請求の範囲において種々の変更が可能である。上記では自然分娩における妊婦の痛みを軽減する実施形態について説明したが、これに限定されない。上記以外にも硬膜外麻酔を用いなければ、妊婦に陣痛促進剤等を投与してもよい。 The present invention is not limited to the above-described embodiment, and various modifications can be made within the scope of the claims. In the above, the embodiment for reducing the pain of a pregnant woman in natural childbirth has been described, but the present invention is not limited thereto. In addition to the above, if epidural anesthesia is not used, a labor-promoting agent or the like may be administered to the pregnant woman.

また、蒸留水15を穿刺箇所P1~P4に注入する際には生体と浸透圧との差によって、蒸留水15の注入時に妊婦は若干の痛みを一時的に感じる。そのため、蒸留水15の代わりとして、滅菌された蒸留水に生理食塩水等を加えてもよい。これにより、浸透圧による刺激を下げつつ、上述した疼痛軽減(除痛)効果を維持することが期待できる。また、妊婦の腰部における穿刺箇所P1~P4に注入する液体は、麻酔科医以外の者でも注入が可能であれば、滅菌蒸留水以外の液体であってもよい。 Further, when the distilled water 15 is injected into the puncture sites P1 to P4, the pregnant woman temporarily feels some pain when the distilled water 15 is injected due to the difference between the living body and the osmotic pressure. Therefore, instead of the distilled water 15, physiological saline or the like may be added to the sterilized distilled water. As a result, it can be expected that the above-mentioned pain-relieving (pain-relieving) effect is maintained while reducing the stimulation by osmotic pressure. Further, the liquid to be injected into the puncture points P1 to P4 in the lumbar region of the pregnant woman may be a liquid other than sterile distilled water as long as it can be injected by a person other than an anesthesiologist.

図6は、図1における医療器具100のシリンジ本体10の変形例を示す部分断面図である。上記では医療器具100が押し子11や外筒12を備えるシリンジ本体10を有すると説明したが、これに限定されない。上記以外にも図6に示すように医療器具100aのシリンジ本体10aは、押し子11aの外側面に長手方向に複数の凸部等の複数の係合部11bを設け、外筒12aの内表面には複数の係合部11bと係合する複数の被係合部12bを設けてもよい。 FIG. 6 is a partial cross-sectional view showing a modified example of the syringe body 10 of the medical device 100 in FIG. 1. Although it has been described above that the medical device 100 has a syringe body 10 including a pusher 11 and an outer cylinder 12, the present invention is not limited to this. In addition to the above, as shown in FIG. 6, the syringe body 10a of the medical device 100a is provided with a plurality of engaging portions 11b such as a plurality of convex portions in the longitudinal direction on the outer surface of the pusher 11a, and the inner surface of the outer cylinder 12a is provided. May be provided with a plurality of engaged portions 12b that engage with the plurality of engaging portions 11b.

複数の係合部11bは、複数の被係合部12bと共に、外筒12aに対して蒸留水15を押し出す移動量を段階的に規制するストッパーのように機能する。複数の被係合部12bは、内腔14を設けた外筒12aの内側に設けられる。上記のように蒸留水15は、腰部の皮内において穿刺箇所P1~P4に注入される。仮に、一箇所につき医療器具を1つ使用すれば、穿刺箇所P1~P4に穿刺するためには医療器具が4本必要になる。 The plurality of engaging portions 11b, together with the plurality of engaged portions 12b, function as stoppers that stepwise regulate the amount of movement of the distilled water 15 with respect to the outer cylinder 12a. The plurality of engaged portions 12b are provided inside the outer cylinder 12a provided with the lumen 14. As described above, the distilled water 15 is injected into the puncture points P1 to P4 in the skin of the lumbar region. If one medical device is used for each site, four medical devices are required to puncture the puncture points P1 to P4.

これについて、複数の係合部11bと複数の被係合部12bを用いて押し子11aを移動させれば、押し子11aを注射針27に向けて移動させても係合部11bが1つ隣り合う被係合部12bと係合して移動が一旦停止する。医師等の医療器具100aの使用者は、係合部11bが隣接する被係合部12bと係合したことを手の感覚(触覚)によって認識(認知)できる。 Regarding this, if the pusher 11a is moved by using the plurality of engaging portions 11b and the plurality of engaged portions 12b, even if the pusher 11a is moved toward the injection needle 27, one engaging portion 11b is provided. The movement is temporarily stopped by engaging with the adjacent engaged portions 12b. A user of the medical device 100a, such as a doctor, can recognize (recognize) that the engaging portion 11b is engaged with the adjacent engaged portion 12b by the sense of the hand (tactile sense).

これにより、一本の医療器具にて複数の穿刺箇所に蒸留水15を注入できる。そのため、穿刺箇所P1~P4への蒸留水注入に必要な医療器具を減らし、保管スペースや廃棄物を削減することができる。また、一本の医療器具により、複数の穿刺箇所へ連続投与することができ、これにより手技の時間短縮等も期待できる。 This makes it possible to inject distilled water 15 into a plurality of puncture points with a single medical device. Therefore, it is possible to reduce the number of medical devices required for injecting distilled water into the puncture points P1 to P4, and reduce the storage space and waste. In addition, one medical device can be used for continuous administration to a plurality of puncture sites, which can be expected to shorten the procedure time.

なお、図6ではテーパー形状を備えた係合部11bと被係合部12bを3つ設けている。ただし、隣接する被係合部と係合することによって係合部の注射針に向けての移動量が規制できれば、係合部及び被係合部の形状や数は図6に限定されない。 In FIG. 6, three engaging portions 11b and three engaged portions 12b having a tapered shape are provided. However, the shape and number of the engaged portion and the engaged portion are not limited to FIG. 6 as long as the amount of movement of the engaged portion toward the injection needle can be regulated by engaging with the adjacent engaged portion.

100、100a 医療器具、
10 シリンジ本体、
11、11a 押し子、
11b 係合部、
12、12a 外筒、
12b 被係合部、
14 内腔、
15 蒸留水(液体)、
20 注射針組立体、
27 注射針(穿刺部)、
32 皮内、
P1~P4 穿刺箇所。
100, 100a medical equipment,
10 Syringe body,
11, 11a pusher,
11b engaging part,
12, 12a outer cylinder,
12b engaged part,
14 lumen,
15 Distilled water (liquid),
20 needle assembly,
27 Injection needle (puncture site),
32 In the skin,
P1 to P4 puncture points.

Claims (5)

内腔と穿刺部とを備え、前記内腔に液体が予め充填された医療器具の前記穿刺部を用いて分娩中の妊婦の腰部における皮内に穿刺箇所を形成し、
前記内腔から前記穿刺箇所に前記液体を注入することによって、子宮収縮により刺激される神経よりも伝導速度の速い神経に刺激を付与する疼痛軽減方法。
Using the puncture portion of a medical device having a lumen and a puncture portion in which the lumen is prefilled with liquid, a puncture site is formed in the skin of the lumbar region of a pregnant woman during delivery.
A pain-relieving method for injecting the liquid from the lumen into the puncture site to stimulate a nerve having a faster conduction rate than a nerve stimulated by uterine contraction.
前記液体は、滅菌された蒸留水を含む請求項1に記載の疼痛軽減方法。 The pain-relieving method according to claim 1, wherein the liquid contains sterilized distilled water. 請求項1又は2に記載の疼痛軽減方法に用いられる液体。 The liquid used for the pain relief method according to claim 1 or 2. 請求項1~3のいずれか1項に記載された前記内腔に前記液体が予め充填された医療器具。 The medical device in which the liquid is pre-filled in the lumen according to any one of claims 1 to 3. 前記内腔に充填された前記液体を前記穿刺部に向けて押出す押し子と、
前記内腔を設けた外筒と、をさらに備え、
前記押し子は、前記外筒に対して前記液体を押出す移動量を段階的に規制する複数の係合部を備え、
前記外筒は、前記内腔を設けた内側に設けられ、前記複数の係合部と係合する被係合部を備える請求項4に記載の医療器具。
A pusher that pushes the liquid filled in the lumen toward the puncture site,
Further provided with an outer cylinder provided with the lumen,
The pusher comprises a plurality of engaging portions that stepwise regulate the amount of movement of the liquid to be pushed out to the outer cylinder.
The medical device according to claim 4, wherein the outer cylinder is provided inside the lumen and is provided with an engaged portion that engages with the plurality of engaging portions.
JP2018209239A 2018-11-06 2018-11-06 Pain relief method, liquid, and medical device Pending JP2022016725A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2018209239A JP2022016725A (en) 2018-11-06 2018-11-06 Pain relief method, liquid, and medical device
PCT/JP2019/030565 WO2020095496A1 (en) 2018-11-06 2019-08-02 Method for reducing pain, liquid and medical instrument

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018209239A JP2022016725A (en) 2018-11-06 2018-11-06 Pain relief method, liquid, and medical device

Publications (1)

Publication Number Publication Date
JP2022016725A true JP2022016725A (en) 2022-01-25

Family

ID=70611899

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018209239A Pending JP2022016725A (en) 2018-11-06 2018-11-06 Pain relief method, liquid, and medical device

Country Status (2)

Country Link
JP (1) JP2022016725A (en)
WO (1) WO2020095496A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60138542U (en) * 1984-02-28 1985-09-13 三菱鉛筆株式会社 syringe
JP2009028527A (en) * 2007-06-28 2009-02-12 Tokai Univ Syringe

Also Published As

Publication number Publication date
WO2020095496A1 (en) 2020-05-14

Similar Documents

Publication Publication Date Title
JP2019088812A (en) Anesthesia applicators/injectors for dental and other applications and methods of use
KR20140034900A (en) Injection apparatus with needle housing for desensitising skin
Wills Rapid onset of massive subdural anesthesia
US20130006218A1 (en) Assisted Injection Device
JP2022016725A (en) Pain relief method, liquid, and medical device
Gorelick et al. James Leonard Corning and the early history of spinal puncture
Yentis Taking the sting out of needles
Tshibuyi et al. Comparative Study on the Efficacy of Two Regimens of Single-Shot Spinal Block for Pain Relief in Women Presenting in Established Labour
Jegasothy Deoxycholate injections used successfully to treat lower abdominal fat in a thin female patient
Somani et al. " No needles.. No Tears.. Engaging smiles for children.".
Macheta et al. The genesis of anaesthesia in prehistory
Leonardo Penile augmentation
Ahmad Comparison of Pain Levels in Anterior Versus Cephalic Approach for Supraorbital/Supratrochlear Nerve Blocks
RU2625654C1 (en) Method for local conservative treatment of myopia
Jankovic et al. Regional nerve blocks and Infiltration therapy in clinical practice
Dominguez Distressing upper extremity phantom limb sensation during intravenous regional anesthesia
Chatterji et al. Obstetric Analgesia
Magora et al. Epidural morphine analgesia in second-trimester induced abortion
Scerrati et al. Surgical treatment of spasticity: intrathecal baclofen pump implantation under subarachnoid block
DEAVER et al. The value and limitations of spinal anesthesia
Niteen Local anesthesia for cosmetic procedures
JPWO2019235637A1 (en) Syringe with movable needle and camouflaged pain point needle
Hameed et al. Anesthesia in Laser Practice
Dong-yan et al. Observation on therapeutic effect of hydro-acupuncture in the treatment of cervical headache
Crombez et al. Remifentanil: an attractive sedative for retrogasserian glycerol injection